Page last updated: 2024-11-04

gatifloxacin and Amentia

gatifloxacin has been researched along with Amentia in 2 studies

Gatifloxacin: A fluoroquinolone antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used as an ophthalmic solution for the treatment of BACTERIAL CONJUNCTIVITIS.
gatifloxacin : A monocarboxylic acid that is 4-oxo-1,4-dihydroquinoline-3-carboxylic acid which is substituted on the nitrogen by a cyclopropyl group and at positions 6, 7, and 8 by fluoro, 3-methylpiperazin-1-yl, and methoxy groups, respectively. Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial topoisomerase type-II enzymes.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Satyanarayana, S1
Campbell, B1
Palmer, TR1

Other Studies

2 other studies available for gatifloxacin and Amentia

ArticleYear
Gatifloxacin-induced delirium and psychosis in an elderly demented woman.
    Journal of the American Geriatrics Society, 2006, Volume: 54, Issue:5

    Topics: Aged, 80 and over; Anti-Infective Agents; Delirium; Dementia; Female; Fluoroquinolones; Gatifloxacin

2006
Delirium was likely due to multiple factors, rather than gatifloxacin induced.
    Journal of the American Geriatrics Society, 2006, Volume: 54, Issue:11

    Topics: Aged, 80 and over; Anti-Infective Agents; Delirium; Dementia; Female; Fluoroquinolones; Gatifloxacin

2006